A Unified System-Wide Electronic Dashboard for Inpatient Glucose Management Across a Large Health System

大型医疗系统内住院血糖管理的统一系统级电子仪表盘

阅读:3

Abstract

BACKGROUND: Despite established guidelines and increasing national hospital quality metrics, achieving consistent inpatient glycemic control remains challenging. A system-wide glucose data monitoring dashboard can help consolidate and visualize key metrics to support quality improvement (QI) and standardize care. METHODS: A web-based diabetes dashboard was implemented across 7 hospitals within a large health care system to monitor monthly data from the electronic health record. Metrics included patient-days with hypoglycemia (<70 mg/dL), hyperglycemia (mean >180 mg/dL), in-hospital mortality, hospital length of stay (LOS), and 30-day readmissions to the emergency department (ED) or inpatient/observation (IP/OBS). A total of 455 303 admissions were analyzed between January 2018 and March 2025, comparing pre-implementation (2018-2022) to post-implementation (2023-2025). Statistical analyses included t tests or Wilcoxon rank-sum tests. Given differences between the large academic site and 6 community hospitals, a difference-in-differences analysis was performed to evaluate impact by hospital type. RESULTS: After implementation of the dashboard, patient-days with hypoglycemia decreased from 4.81% to 4.15%, hyperglycemia from 25.30% to 23.46%, mortality from 2.69% to 2.13%, and LOS from 7.56 to 7.29 days (all P < .01). Emergency department and IP/OBS readmissions increased slightly (P < .01 and P = .01, respectively). Comparing the community hospitals to the academic, statistically significant reductions were observed in hypoglycemia, hyperglycemia, and mortality but with increased ED readmissions. There were no differences in LOS or IP/OBS readmission. CONCLUSIONS: Implementation of a system-wide electronic dashboard was associated with improved glycemic control, mortality, and LOS. Dashboards can effectively support multidisciplinary collaboration and QI in diverse hospital settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。